Trademark search for:

EFTINOV

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2006-03-29 — Application filed
2006-04-04 — Application filed
2006-07-03 — Assigned to examiner
2006-07-10 — Examiners amendment -written
2006-07-10 — Approved for pub - principal register
2006-07-10 — Examiners amendment e-mailed
2006-07-10 — Examiner's amendment entered
2006-07-21 — Assigned to lie
2006-07-27 — Law office publication review completed
2006-08-30 — Notice of publication
2006-09-19 — Published for opposition
2006-12-05 — Registered-principal register
2008-11-04 — Attorney/dom.rep.revoked and/or appointed
2008-11-04 — Teas revoke/app/change addr of atty/dom rep received
2010-01-12 — Teas section 7 request received
2010-01-16 — Case assigned to post registration paralegal
2010-01-16 — Amendment under section 7 - processed
2013-07-12 — Cancelled sec. 8 (6-yr)
2013-07-12 — Final status recorded

Owner Information

Novartis AG
Basel CH

Correspondent

Nancy Sabarra Fross Zelnick Lehrman & Zissu, P.C.
866 United Nations Plaza
New York, NY 10017
UNITED STATES

Filing Details

Filing Date:
2006-03-29

Status Date:
2013-07-12

Category:
Pharmaceuticals

Filing Year:
2002

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.